Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-01-02 @ 8:07 AM
Study NCT ID:
NCT02469857
Status:
COMPLETED
Last Update Posted:
2021-10-05
First Post:
2015-06-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections
Sponsor:
Atox Bio Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-18
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-06
First Submit QC Date:
None
Study First Post Date:
2015-06-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-09-03
Results First Submit QC Date:
None
Results First Post Date:
2021-10-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-01-27
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-10-02
Last Update Post Date:
2021-10-05
Last Update Post Date Type:
ACTUAL